marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q2
added 08-12-2022
PhaseBio Pharmaceuticals Financial Statements 2011-2024 | PHAS
Annual Financial Statements PhaseBio Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
87.8 M | 113 M | 134 M | 18.8 M | - | - | - | - | - | - | - |
Shares |
43.9 M | 29.4 M | 27.5 M | 5.31 M | - | - | - | - | - | - | - |
Historical Prices |
2.61 | 3.36 | 6.11 | 3.09 | - | - | - | - | - | - | - |
Net Income |
-131 M | -98.6 M | -39.2 M | -23.8 M | -10.2 M | -9.22 M | - | - | - | - | - |
Revenue |
10.8 M | 320 K | 2.36 M | 668 K | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | 320 | - | - | - | - | - | - | - | - | - |
Operating Income |
-107 M | -84.9 M | -39.7 M | -19.6 M | -8.54 M | - | - | - | - | - | - |
Interest Expense |
947 K | 1.44 M | 1.08 M | 3.92 M | 2.72 M | - | - | - | - | - | - |
EBITDA |
-106 M | -84.3 M | -39.6 M | -19.5 M | -8.39 M | -9.38 M | - | - | - | - | - |
Operating Expenses |
118 M | 85.2 M | 42.1 M | 20.3 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
16.1 M | 13.1 M | 11.2 M | 4.86 M | 2.33 M | 2.12 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement PhaseBio Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | 49.2 M | 48.6 M | 48.2 M | 48 M | 48 M | 31.3 M | 29.4 M | 29.2 M | 28.8 M | 28.8 M | 28.8 M | 28.7 M | 27.9 M | 24.5 M | 24.5 M | 756 K | 746 K | 746 K | 746 K | 743 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
- | - | -16.7 M | -11.1 M | - | -31.9 M | -28.7 M | -27.4 M | - | -25.1 M | -28.1 M | -14.9 M | - | -11.4 M | -9.23 M | -7.29 M | - | -7.9 M | -6.67 M | -4.4 M | - | -2.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | 208 K | 117 K | - | 335 K | 10.3 M | - | - | - | - | 320 K | - | 241 K | 703 K | 653 K | - | 411 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | -25.3 M | -18.2 M | - | -28.6 M | -21.1 M | -25.6 M | - | -20.5 M | -24.1 M | -14.3 M | - | -11.6 M | -9.48 M | -7.38 M | - | -5 M | -4.11 M | -2.88 M | - | -1.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | 116 K | 148 K | - | 222 K | 254 K | 285 K | - | 362 K | 379 K | 378 K | - | 266 K | 219 K | 226 K | - | 890 K | 1.45 M | 1.4 M | - | 618 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -24.1 M | -17.6 M | - | -28.5 M | -20 M | -25.2 M | - | -20.3 M | -24 M | -14.2 M | - | -11.5 M | -9.41 M | -7.35 M | - | -4.92 M | -4.05 M | -2.85 M | - | -1.83 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | 25.5 M | 18.3 M | - | 28.9 M | 31.4 M | 25.6 M | - | 20.5 M | 24.1 M | 14.6 M | - | 11.8 M | 10.2 M | 8.04 M | - | 5.41 M | 4.11 M | 2.88 M | - | 1.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | 4.58 M | 4.01 M | - | 3.84 M | 4.02 M | 3.33 M | - | 3.08 M | 3.24 M | 3.16 M | - | 2.8 M | 2.4 M | 2.32 M | - | 1.06 M | 917 K | 643 K | - | 565 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency